Lung Cancer Trial, Not Yet Recruiting NCT07627022 Sponsor: University Hospital Schleswig-Holstein Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07627022
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A diagnosis of lung cancer that has been confirmed through laboratory testing of tissue samples.
  • Having received at least 50 Gy of standard radiation therapy as part of treatment.
  • Owning and being able to use a smartphone and a step counter.
  • Being 18 years of age or older.
  • Being willing and able to provide written informed consent.
  • Having the mental capacity to give consent to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are expected to have difficulty following the trial's requirements or instructions.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dirk Rades, Prof. Dr., Department of Radiation Oncology, University of Luebeck, Germany

Phone: 0049-451-500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
University Hospital Schleswig-Holstein
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
15 February 2027

Where this trial is recruiting

🇩🇰 Denmark 🇬🇪 Georgia 🇩🇪 Germany 🇸🇮 Slovenia

Primary endpoints

Mean number of steps per week during week 1 and week 5 of radiation therapy for lung cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov